Response to [Time zero alignment in target trial emulation of VMAT2 inhibitors versus anticholinergics for tardive dyskinesia]
Tien‐Wei Hsu, Chia‐Kuang Tsai, Chih‐Sung Liang · 2026
Read Response to [Time zero alignment in target trial emulation of VMAT2 inhibitors versus anticholinergics for tardive dyskinesia] by Tien‐Wei Hsu, Chia‐Kuang Tsai, Chih‐Sung Liang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13447120.txt.
Description
Tien-Wei Hsu, Chia-Kuang Tsai and Chih-Sung Liang reply in 2026 to a comment on their study comparing two drug groups for tardive dyskinesia, a movement disorder linked to some medicines. Critics had questioned how the start of follow-up, called time zero, was set. Fair comparison depends on both groups starting at a similar point in care.
The authors explain that diagnosis and treatment both had to fall in the same recent period, from early 2019 to mid 2025. That window ensured both approved drugs in one group were in routine use. They also reran the work requiring treatment to start after diagnosis. Sample size barely changed, and the risk estimates stayed much the same, which they offer as reassurance about the original design.
Catalog record
| CREATOR | Tien‐Wei Hsu, Chia‐Kuang Tsai, Chih‐Sung Liang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2098 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |